On the public citation graph

Vaccines for the 21st century

0 signed · 540 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.1990.03440150134043openalex-snapshot
Fundamental Immunology
inferredcites →https://doi.org/10.1001/jama.2011.100openalex-snapshot
Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants
inferredcites →https://doi.org/10.1001/jama.2013.3010openalex-snapshot
Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery
inferredcites →https://doi.org/10.1002/14651858.cd002959.pub2openalex-snapshot
Vaccines for women to prevent neonatal tetanus
inferredcites →https://doi.org/10.1002/14651858.cd002959.pub3openalex-snapshot
Vaccines for women to prevent neonatal tetanus
inferredcites →https://doi.org/10.1002/14651858.cd002959.pub4openalex-snapshot
Vaccines for women for preventing neonatal tetanus
inferredcites →https://doi.org/10.1007/978-3-642-38919-1_4openalex-snapshot
Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins
inferredcites →https://doi.org/10.1007/s00281-006-0047-yopenalex-snapshot
Cytokine-adjuvanted HIV-DNA vaccination strategies
inferredcites →https://doi.org/10.1007/s00281-011-0293-5openalex-snapshot
Development of a vaccine against Staphylococcus aureus
inferredcites →https://doi.org/10.1016/0020-711x(92)90281-5openalex-snapshot
New generation vaccines
inferredcites →https://doi.org/10.1016/0035-9203(93)90156-kopenalex-snapshot
Yellow fever vaccination and pregnancy: a four-year prospective study
inferredcites →https://doi.org/10.1016/b978-0-12-396548-6.00002-0openalex-snapshot
Structure-Based Design for High-Hanging Vaccine Fruits
inferredcites →https://doi.org/10.1016/b978-1-4160-3611-1.50033-7openalex-snapshot
Rubella vaccine
inferredcites →https://doi.org/10.1016/j.ajog.2010.08.050openalex-snapshot
Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009
inferredcites →https://doi.org/10.1016/j.cell.2006.02.015openalex-snapshot
Pathogen Recognition and Innate Immunity
inferredcites →https://doi.org/10.1016/j.chom.2012.09.008openalex-snapshot
A Blueprint for HIV Vaccine Discovery
inferredcites →https://doi.org/10.1016/j.coi.2009.05.003openalex-snapshot
Immunology of TLR-independent vaccine adjuvants
inferredcites →https://doi.org/10.1016/j.coi.2011.03.006openalex-snapshot
Viral vectors as vaccine platforms: deployment in sight
inferredcites →https://doi.org/10.1016/j.coi.2011.03.008openalex-snapshot
Electroporation delivery of DNA vaccines: prospects for success
inferredcites →https://doi.org/10.1016/j.coviro.2013.05.010openalex-snapshot
Advances in structure-based vaccine design
inferredcites →https://doi.org/10.1016/j.ijantimicag.2008.06.009openalex-snapshot
Vaccination and passive immunisation against Staphylococcus aureus
inferredcites →https://doi.org/10.1016/j.ijmm.2010.04.015openalex-snapshot
Immunotherapeutic strategies to combat staphylococcal infections
inferredcites →https://doi.org/10.1016/j.immuni.2010.09.015openalex-snapshot
Future Vaccination Strategies against Tuberculosis: Thinking outside the Box
inferredcites →https://doi.org/10.1016/j.immuni.2010.10.004openalex-snapshot
Immunologic Basis of Vaccine Vectors
inferredcites →https://doi.org/10.1016/j.immuni.2010.10.006openalex-snapshot
Systems Vaccinology
inferredcites →https://doi.org/10.1016/j.it.2012.03.004openalex-snapshot
Tuberculosis vaccine development: strength lies in tenacity
inferredcites →https://doi.org/10.1016/j.patbio.2009.03.004openalex-snapshot
La vaccination : atout majeur dans la lutte contre le cancer du foie induit par le virus de l’hépatite B
inferredcites →https://doi.org/10.1016/j.smim.2013.05.001openalex-snapshot
RNA: The new revolution in nucleic acid vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2006.06.005openalex-snapshot
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only
inferredcites →https://doi.org/10.1016/j.vaccine.2006.11.066openalex-snapshot
Development and registration of recombinant veterinary vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2009.09.033openalex-snapshot
Poxvirus-vectored vaccines for rabies—A review
inferredcites →https://doi.org/10.1016/j.vaccine.2011.09.114openalex-snapshot
Flaviviruses and flavivirus vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2011.11.006openalex-snapshot
Is there a future for a Staphylococcus aureus vaccine?
inferredcites →https://doi.org/10.1016/j.vaccine.2011.12.045openalex-snapshot
The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies
inferredcites →https://doi.org/10.1016/j.vaccine.2012.05.035openalex-snapshot
Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
inferredcites →https://doi.org/10.1016/j.vaccine.2012.10.115openalex-snapshot
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2013.04.002openalex-snapshot
Vaccine review: “Staphyloccocus aureus vaccines: Problems and prospects”
inferredcites →https://doi.org/10.1016/s0140-6736(07)61261-6openalex-snapshot
Maternal and neonatal tetanus
inferredcites →https://doi.org/10.1016/s0140-6736(08)61591-3openalex-snapshot
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
inferredcites →https://doi.org/10.1016/s0140-6736(08)61592-5openalex-snapshot
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
inferredcites →https://doi.org/10.1016/s0140-6736(12)61428-7openalex-snapshot
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
inferredcites →https://doi.org/10.1016/s0140-6736(12)61510-4openalex-snapshot
Dengue vaccine development: a 75% solution?
inferredcites →https://doi.org/10.1016/s0140-6736(13)60177-4openalex-snapshot
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
inferredcites →https://doi.org/10.1016/s1369-5274(00)00119-3openalex-snapshot
Reverse vaccinology
inferredcites →https://doi.org/10.1016/s1473-3099(10)70262-0openalex-snapshot
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial
inferredcites →https://doi.org/10.1016/s1473-3099(11)70098-6openalex-snapshot
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
inferredcites →https://doi.org/10.1016/s1473-3099(13)70005-7openalex-snapshot
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
inferredcites →https://doi.org/10.1016/s1473-3099(13)70028-8openalex-snapshot
Dengue vaccine efficacy trial: does interference cause failure?
inferredcites →https://doi.org/10.1038/mt.2010.289openalex-snapshot
Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
inferredcites →https://doi.org/10.1038/nature12744openalex-snapshot
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
inferredcites →https://doi.org/10.1038/nature12746openalex-snapshot
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
inferredcites →https://doi.org/10.1038/nbt1197-1285openalex-snapshot
Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector
inferredcites →https://doi.org/10.1038/nbt1213-1066aopenalex-snapshot
GSK plows ahead with EMA malaria vaccine submission
inferredcites →https://doi.org/10.1038/ni.1688openalex-snapshot
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
inferredcites →https://doi.org/10.1038/ni1004-971openalex-snapshot
The interface between innate and adaptive immunity
inferredcites →https://doi.org/10.1038/nm0498-397openalex-snapshot
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
inferredcites →https://doi.org/10.1038/nri3085openalex-snapshot
Vaccines for the twenty-first century society
inferredcites →https://doi.org/10.1038/nri3516openalex-snapshot
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
inferredcites →https://doi.org/10.1056/nejmoa011297openalex-snapshot
Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis
inferredcites →https://doi.org/10.1056/nejmoa0708630openalex-snapshot
Effectiveness of Maternal Influenza Immunization in Mothers and Infants
inferredcites →https://doi.org/10.1056/nejmoa0807381openalex-snapshot
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
inferredcites →https://doi.org/10.1056/nejmoa0908492openalex-snapshot
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
inferredcites →https://doi.org/10.1056/nejmoa1001294openalex-snapshot
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1056/nejmoa1003466openalex-snapshot
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1102287openalex-snapshot
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
inferredcites →https://doi.org/10.1056/nejmoa1113425openalex-snapshot
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
inferredcites →https://doi.org/10.1056/nejmoa1305133openalex-snapshot
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
inferredcites →https://doi.org/10.1073/pnas.0603940103openalex-snapshot
A universal vaccine for serogroup B meningococcus
inferredcites →https://doi.org/10.1073/pnas.1106536108openalex-snapshot
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
inferredcites →https://doi.org/10.1073/pnas.1209367109openalex-snapshot
Nonviral delivery of self-amplifying RNA vaccines
inferredcites →https://doi.org/10.1084/jem.20082292openalex-snapshot
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
inferredcites →https://doi.org/10.1086/428404openalex-snapshot
Placebo‐Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV‐1 Infection
inferredcites →https://doi.org/10.1086/508748openalex-snapshot
Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand
inferredcites →https://doi.org/10.1086/605845openalex-snapshot
Cost‐Effectiveness of a Potential ProphylacticHelicobacter pyloriVaccine in the United States
inferredcites →https://doi.org/10.1086/649916openalex-snapshot
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
inferredcites →https://doi.org/10.1093/cid/cir334openalex-snapshot
Clinical Applications of DNA Vaccines: Current Progress
inferredcites →https://doi.org/10.1093/infdis/jir489openalex-snapshot
Rubella Vaccination of Unknowingly Pregnant Women During Mass Campaigns for Rubella and Congenital Rubella Syndrome Elimination, The Americas 2001-2008
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a120955openalex-snapshot
RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12
inferredcites →https://doi.org/10.1097/cji.0b013e31815ce501openalex-snapshot
Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
inferredcites →https://doi.org/10.1097/cji.0b013e3181a00068openalex-snapshot
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
inferredcites →https://doi.org/10.1097/coh.0b013e32833d2d2bopenalex-snapshot
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine
inferredcites →https://doi.org/10.1097/grf.0b013e31824f3acbopenalex-snapshot
Vaccines in Pregnant Women and Research Initiatives
inferredcites →https://doi.org/10.1097/inf.0b013e3181fe05afopenalex-snapshot
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City
inferredcites →https://doi.org/10.1126/science.1092556openalex-snapshot
Inflammatory Exposure and Historical Changes in Human Life-Spans
inferredcites →https://doi.org/10.1126/science.1234150openalex-snapshot
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
inferredcites →https://doi.org/10.1126/science.1234914openalex-snapshot
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
inferredcites →https://doi.org/10.1126/science.1243283openalex-snapshot
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
inferredcites →https://doi.org/10.1126/science.1245625openalex-snapshot
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
inferredcites →https://doi.org/10.1126/science.1245627openalex-snapshot
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
inferredcites →https://doi.org/10.1126/science.287.5459.1816openalex-snapshot
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
inferredcites →https://doi.org/10.1126/science.3277268openalex-snapshot
Pathogenesis of Dengue: Challenges to Molecular Biology
inferredcites →https://doi.org/10.1126/science.342.6165.1432openalex-snapshot
Cancer Immunotherapy
inferredcites →https://doi.org/10.1126/scitranslmed.3004414openalex-snapshot
Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses
inferredcites →https://doi.org/10.1126/scitranslmed.3006368openalex-snapshot
Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics
inferredcites →https://doi.org/10.1128/cvi.00034-12openalex-snapshot
Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis
inferredcites →https://doi.org/10.1128/cvi.00356-10openalex-snapshot
Safety and Immunogenicity of a Novel Staphylococcus aureus Vaccine: Results from the First Study of the Vaccine Dose Range in Humans
inferredcites →https://doi.org/10.1128/jvi.75.9.4040-4047.2001openalex-snapshot
West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays
inferredcites →https://doi.org/10.1146/annurev-immunol-032712-095916openalex-snapshot
Broadly Neutralizing Antiviral Antibodies
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2012.43.7111openalex-snapshot
Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
inferredcites →https://doi.org/10.1371/journal.pone.0032587openalex-snapshot
Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission
inferredcites →https://doi.org/10.1371/journal.ppat.1002607openalex-snapshot
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
inferredcites →https://doi.org/10.1371/journal.ppat.1003264openalex-snapshot
Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
inferredcites →https://doi.org/10.1517/14712598.2010.495115openalex-snapshot
Novel targeted immunotherapy approaches for staphylococcal infection
inferredcites →https://doi.org/10.1586/14760584.2013.836914openalex-snapshot
Live-attenuated bacteria as a cancer vaccine vector
inferredcites →https://doi.org/10.1586/eri.12.43openalex-snapshot
Diagnosis of extrapulmonary tuberculosis using the Xpert®MTB/RIF assay
inferredcites →https://doi.org/10.1586/erv.09.113openalex-snapshot
10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix™
inferredcites →https://doi.org/10.1586/erv.10.54openalex-snapshot
New Generation Vaccines
inferredcites →https://doi.org/10.1586/erv.13.11openalex-snapshot
Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets
inferredcites →https://doi.org/10.2105/ajph.18.8.1075-aopenalex-snapshot
La Vaccination Préventive Contre la Tuberculose par le “BCG”
inferredcites →https://doi.org/10.2165/00003495-200666090-00008openalex-snapshot
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil??)
inferredcites →https://doi.org/10.2165/00003495-200868030-00007openalex-snapshot
Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix???]
inferredcites →https://doi.org/10.2165/11205110-000000000-00000openalex-snapshot
Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]
inferredcites →https://doi.org/10.2165/11207140-000000000-00000openalex-snapshot
Sipuleucel-T in Metastatic Castration-Resistant Prostate Cancer†
inferredcites →https://doi.org/10.2165/11209330-000000000-00000openalex-snapshot
Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed)
inferredcites →https://doi.org/10.2460/ajvr.72.12.1631openalex-snapshot
Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor
inferredcites →https://doi.org/10.3354/dao064013openalex-snapshot
Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon
inferredcites →https://doi.org/10.3389/fimmu.2013.00354openalex-snapshot
Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
inferredcites →https://doi.org/10.4161/hv.2.2.2555openalex-snapshot
Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All
inferredcites →https://doi.org/10.4161/hv.7.2.13690openalex-snapshot
Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines
inferredcites →https://doi.org/10.4269/ajtmh.2009.80.302openalex-snapshot
Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3800383openalex-extracted
Novel Potent Neutralizing Antibodies Revealed the Domain I of HCMV Glycoprotein B for Vaccine Design
inferred← citeshttps://doi.org/10.1002/14651858.cd012805openalex-snapshot
Aluminium adjuvants used in vaccines versus placebo or no intervention
inferred← citeshttps://doi.org/10.1002/14651858.cd013086openalex-snapshot
Aluminium adjuvants used in vaccines
inferred← citeshttps://doi.org/10.1002/9781119858430.ch8openalex-snapshot
Vaccines, Vaccinosis, and Autoimmunity
inferred← citeshttps://doi.org/10.1002/9781119874096.ch17openalex-snapshot
Molecular Farming and Anticancer Vaccine
inferred← citeshttps://doi.org/10.1002/adfm.202000346openalex-snapshot
Bionanoparticle‐Based Delivery in Antihypertensive Vaccine Mediates DC Activation through Lipid‐Raft Reorganization
inferred← citeshttps://doi.org/10.1002/adhm.201701439openalex-snapshot
Photothermally Controlled MHC Class I Restricted CD8+ T‐Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/anbr.202100082openalex-snapshot
Amphiphilic Cyclodextrin‐Based Nanoparticulate Vaccines Can Trigger T‐Cell Immune Responses
inferred← citeshttps://doi.org/10.1002/ange.202010282openalex-snapshot
Biopolymer‐based Carriers for DNA Vaccine Design
inferred← citeshttps://doi.org/10.1002/anie.202010282openalex-snapshot
Biopolymer‐based Carriers for DNA Vaccine Design
inferred← citeshttps://doi.org/10.1002/biot.202400091openalex-snapshot
Microalgae‐made human vaccines and therapeutics: A decade of advances
inferred← citeshttps://doi.org/10.1002/bit.25884openalex-snapshot
Targeting soluble proteins to exosomes using a ubiquitin tag
inferred← citeshttps://doi.org/10.1002/cbic.202000343openalex-snapshot
Genetic‐Code‐Expansion Strategies for Vaccine Development
inferred← citeshttps://doi.org/10.1002/cnma.202100505openalex-snapshot
Nanotechnology Toolkit for Combating COVID‐19 and Beyond
inferred← citeshttps://doi.org/10.1002/eji.201570075openalex-snapshot
4th European Congress of Immunology – ECI 2015
inferred← citeshttps://doi.org/10.1002/jmv.28032openalex-snapshot
Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26.COV2.S vaccines
inferred← citeshttps://doi.org/10.1002/ps.5752openalex-snapshot
Patterns of insecticide resistance in Aedes aegypti: meta‐analyses of surveys in Latin America and the Caribbean
inferred← citeshttps://doi.org/10.1002/wnan.1681openalex-snapshot
Advancements in protein nanoparticle vaccine platforms to combat infectious disease
inferred← citeshttps://doi.org/10.1007/10_2020_132openalex-snapshot
Impact of Protein Glycosylation on the Design of Viral Vaccines
inferred← citeshttps://doi.org/10.1007/978-1-0716-1884-4_1openalex-snapshot
Challenges for Vaccinologists in the First Half of the Twenty-First Century
inferred← citeshttps://doi.org/10.1007/978-1-0716-1892-9_8openalex-snapshot
Developments in Vaccine Adjuvants
inferred← citeshttps://doi.org/10.1007/978-3-030-03095-7_36openalex-snapshot
Muscle as a Potent Target in Vaccination
inferred← citeshttps://doi.org/10.1007/978-3-030-51927-8_1openalex-snapshot
Introduction to Veterinary Vaccines
inferred← citeshttps://doi.org/10.1007/978-3-030-52663-4_13openalex-snapshot
Immunity and Health
inferred← citeshttps://doi.org/10.1007/978-3-030-71165-8_29openalex-snapshot
Vaccines for Emerging Viruses—A Comprehensive Update
inferred← citeshttps://doi.org/10.1007/978-3-030-89664-5_17openalex-snapshot
Antifungal Vaccines: Current Status and Future Directions
inferred← citeshttps://doi.org/10.1007/978-3-030-94350-9_41openalex-snapshot
Application of GIS in Vaccine Distribution During COVID-19
inferred← citeshttps://doi.org/10.1007/978-3-031-07040-2_14openalex-snapshot
Tuberculosis and Human Immunodeficiency Virus Co-infection
inferred← citeshttps://doi.org/10.1007/978-3-031-24323-3_1openalex-snapshot
A Short Introduction to Vaccines
inferred← citeshttps://doi.org/10.1007/978-3-031-24323-3_6openalex-snapshot
Applications of Spray-Dried Vaccines
inferred← citeshttps://doi.org/10.1007/978-3-031-24323-3_7openalex-snapshot
Conclusions and Future Perspectives of Spray-Dried Vaccines
inferred← citeshttps://doi.org/10.1007/978-3-031-24942-6_9openalex-snapshot
The Importance of Vaccines in a Sustainable Healthy Society
inferred← citeshttps://doi.org/10.1007/978-3-031-62772-9_8openalex-snapshot
C. Everett Koop Healthcare System for Biosecurity and Defense
inferred← citeshttps://doi.org/10.1007/978-3-031-77911-4_33openalex-snapshot
A Review on Conventional and Emerging Methods in Vaccinology: A Case Study on COVID-19
inferred← citeshttps://doi.org/10.1007/978-3-031-77911-4_7openalex-snapshot
Reverse and Structural Viral and Bacterial Vaccine Design
inferred← citeshttps://doi.org/10.1007/978-3-031-85340-1_11openalex-snapshot
Trained Innate Immunity
inferred← citeshttps://doi.org/10.1007/978-3-032-29006-9_3openalex-snapshot
Type of Vaccines and their Preparation
inferred← citeshttps://doi.org/10.1007/978-3-319-73148-3_15openalex-snapshot
Biomedical Applications
inferred← citeshttps://doi.org/10.1007/978-981-15-3350-1_1openalex-snapshot
Vaccine Design, Nanoparticle Vaccines and Biomaterial Applications
inferred← citeshttps://doi.org/10.1007/978-981-16-2666-1_7openalex-snapshot
The Application of DNA Nanostructures in Vaccine Technology
inferred← citeshttps://doi.org/10.1007/978-981-16-6379-6_6openalex-snapshot
Advancements in the Field of Oral, Intravenous, and Inhaled Immunomodulators Using Nanotechnology
inferred← citeshttps://doi.org/10.1007/978-981-19-3979-2_8openalex-snapshot
Recombinant Vaccines: The Revolution Ahead
inferred← citeshttps://doi.org/10.1007/978-981-92-1034-3_8openalex-snapshot
Advanced Nanoparticles for Vaccine Development
inferred← citeshttps://doi.org/10.1007/978-981-95-1426-7_17openalex-snapshot
COVID-19 Vaccine: Classification, Development, and Clinical Status
inferred← citeshttps://doi.org/10.1007/978-981-96-3698-3_7openalex-snapshot
COVIDGAME: The Vaccination Battle
inferred← citeshttps://doi.org/10.1007/978-981-97-6270-5_4openalex-snapshot
Industrial Microbial Bioprocess Development: A Comprehensive Overview
inferred← citeshttps://doi.org/10.1007/978-981-99-5744-6_1openalex-snapshot
Introduction: A Broad Perspective on the Concepts of Urban Dynamics, Environment, and Health
inferred← citeshttps://doi.org/10.1007/s00253-019-10106-8openalex-snapshot
Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy
inferred← citeshttps://doi.org/10.1007/s00262-016-1923-5openalex-snapshot
Immunological effects of a novel RNA-based adjuvant in liver cancer patients
inferred← citeshttps://doi.org/10.1007/s00281-024-01015-8openalex-snapshot
Metabolic Regulation in the Induction of Trained Immunity
inferred← citeshttps://doi.org/10.1007/s00430-017-0507-0openalex-snapshot
Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid
inferred← citeshttps://doi.org/10.1007/s00705-019-04273-2openalex-snapshot
Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins
inferred← citeshttps://doi.org/10.1007/s10162-016-0606-4openalex-snapshot
Cytomegalovirus (CMV) Infection Causes Degeneration of Cochlear Vasculature and Hearing Loss in a Mouse Model
inferred← citeshttps://doi.org/10.1007/s10499-022-00884-wopenalex-snapshot
A review on the recent advances and application of vaccines against fish pathogens in aquaculture
inferred← citeshttps://doi.org/10.1007/s10969-016-9207-zopenalex-snapshot
Successful completion of a semi-automated enzyme-free cloning method
inferred← citeshttps://doi.org/10.1007/s10989-025-10785-0openalex-snapshot
Computational and Experimental Approaches for the Development of Epitope-Based Vaccine Against Respiratory Syncytial Virus
inferred← citeshttps://doi.org/10.1007/s11051-023-05867-3openalex-snapshot
Potential and risks of nanotechnology applications in COVID-19-related strategies for pandemic control
inferred← citeshttps://doi.org/10.1007/s11686-024-00897-wopenalex-snapshot
MicroRNA Guided In Silico Drug Repositioning for Malaria
inferred← citeshttps://doi.org/10.1007/s11904-019-00432-xopenalex-snapshot
The Antibodiome—Mapping the Humoral Immune Response to HIV
inferred← citeshttps://doi.org/10.1007/s12098-019-02981-wopenalex-snapshot
Does Food Allergy Require Any Change in Measles-Mumps-Rubella Vaccination?
inferred← citeshttps://doi.org/10.1007/s13337-023-00824-zopenalex-snapshot
HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective
inferred← citeshttps://doi.org/10.1007/s13346-021-00924-7openalex-snapshot
Development of vaccine formulations: past, present, and future
inferred← citeshttps://doi.org/10.1007/s40005-021-00537-9openalex-snapshot
Recent advances in nano/microparticle-based oral vaccines
inferred← citeshttps://doi.org/10.1007/s40199-020-00371-8openalex-snapshot
COVID-19 vaccines: ethical framework concerning human challenge studies
inferred← citeshttps://doi.org/10.1007/s40820-024-01533-yopenalex-snapshot
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-801814-9.00011-8openalex-snapshot
Vaccines and Immunodrugs Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-12-813687-4.00006-2openalex-snapshot
Plasmid-DNA lipid nanovaccines
inferred← citeshttps://doi.org/10.1016/b978-0-12-814515-9.00121-1openalex-snapshot
Vaccine Production, Safety, and Efficacy
inferred← citeshttps://doi.org/10.1016/b978-0-12-815770-1.00031-6openalex-snapshot
Immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-816352-8.00017-5openalex-snapshot
Biotechnological approaches to fish vaccine
inferred← citeshttps://doi.org/10.1016/b978-0-12-816352-8.00018-7openalex-snapshot
Contemporary vaccine approaches and role of next-generation vaccine adjuvants in managing viral diseases
inferred← citeshttps://doi.org/10.1016/b978-0-12-816913-1.00008-8openalex-snapshot
Chitosan-based nanoparticles: promising biomedical applications in specific drug delivery and targeting
inferred← citeshttps://doi.org/10.1016/b978-0-12-817534-7.00016-1openalex-snapshot
Immunity
inferred← citeshttps://doi.org/10.1016/b978-0-12-824156-1.00004-2openalex-snapshot
Progress in the development of vaccines against human papillomavirus
inferred← citeshttps://doi.org/10.1016/b978-0-323-39981-4.00011-7openalex-snapshot
Virus-Like Particles
inferred← citeshttps://doi.org/10.1016/b978-0-323-85844-1.00006-4openalex-snapshot
Vaccine Development Through Reverse Vaccinology Using Artificial Intelligence and Machine Learning Approach
inferred← citeshttps://doi.org/10.1016/b978-0-323-90792-7.00002-6openalex-snapshot
Nanovaccines delivery approaches against infectious diseases
inferred← citeshttps://doi.org/10.1016/b978-0-323-91684-4.00023-2openalex-snapshot
Current applications of biomolecules in biopharmaceuticals and drug discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-13395-4.00024-1openalex-snapshot
Bioinformatics approach to design peptide vaccines for viruses
inferred← citeshttps://doi.org/10.1016/b978-0-443-15378-5.00018-8openalex-snapshot
Bioprocess strategies for the efficient production of DNA vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-443-18564-9.00027-8openalex-snapshot
The fast-track development of COVID-19 vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-443-18564-9.00028-xopenalex-snapshot
History of vaccination
inferred← citeshttps://doi.org/10.1016/b978-0-443-22167-5.00004-6openalex-snapshot
Concept and importance of vaccination
inferred← citeshttps://doi.org/10.1016/b978-0-443-27461-9.00003-2openalex-snapshot
Vaccines as preventive measures
inferred← citeshttps://doi.org/10.1016/b978-0-444-63660-7.00017-6openalex-snapshot
Recombinant Veterinary Vaccines
inferred← citeshttps://doi.org/10.1016/bs.adgen.2019.12.002openalex-snapshot
Antibiotic drug discovery: Challenges and perspectives in the light of emerging antibiotic resistance
inferred← citeshttps://doi.org/10.1016/j.actbio.2018.11.023openalex-snapshot
Alum-functionalized graphene oxide nanocomplexes for effective anticancer vaccination
inferred← citeshttps://doi.org/10.1016/j.addr.2018.06.025openalex-snapshot
Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases
inferred← citeshttps://doi.org/10.1016/j.addr.2021.01.002openalex-snapshot
Nanocarrier vaccines for SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.addr.2024.115292openalex-snapshot
Clinical perspective on topical vaccination strategies
inferred← citeshttps://doi.org/10.1016/j.arcmed.2023.02.003openalex-snapshot
Protein-based Nanoparticle Vaccine Approaches Against Infectious Diseases
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2019.119268openalex-snapshot
Single-injecting, bioinspired nanocomposite hydrogel that can recruit host immune cells in situ to elicit potent and long-lasting humoral immune responses
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2026.124253openalex-snapshot
Adhesive adjuvant protein for long-lasting immune response in vaccination
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117187openalex-snapshot
Original antigenic sin: A potential double-edged effect for vaccine improvement
inferred← citeshttps://doi.org/10.1016/j.biori.2017.10.001openalex-snapshot
The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2015.05.010openalex-snapshot
Nanoengineering of vaccines using natural polysaccharides
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2017.03.005openalex-snapshot
Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines
inferred← citeshttps://doi.org/10.1016/j.bmcl.2021.127920openalex-snapshot
Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.11.039openalex-snapshot
Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
inferred← citeshttps://doi.org/10.1016/j.cca.2015.03.004openalex-snapshot
Neonatal and pediatric healthcare worldwide: A report from UNICEF
inferred← citeshttps://doi.org/10.1016/j.cellimm.2018.11.005openalex-snapshot
Inclusion of non-target antigen in vaccination favors generation of OVA specific CD4 memory T cells
inferred← citeshttps://doi.org/10.1016/j.cjca.2023.03.020openalex-snapshot
Viral Heart Disease: Diagnosis, Management, and Mechanisms
inferred← citeshttps://doi.org/10.1016/j.coi.2015.04.003openalex-snapshot
Understanding the host–pathogen interaction saves lives: lessons from vaccines and vaccinations
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2020.104203openalex-snapshot
Identification and evaluation of immunogenic MHC-I and MHC-II binding peptides from Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.coviro.2015.03.001openalex-snapshot
Lessons from Reverse Vaccinology for viral vaccine design
inferred← citeshttps://doi.org/10.1016/j.csbj.2021.07.035openalex-snapshot
Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2022.02.002openalex-snapshot
The Coronavirus pandemic – 2022: Viruses, variants & vaccines
inferred← citeshttps://doi.org/10.1016/j.dcit.2025.100048openalex-snapshot
mRNA vaccination facilitates the prevention and control of infectious diseases at an unprecedented speed
inferred← citeshttps://doi.org/10.1016/j.eimc.2015.06.013openalex-snapshot
El desarrollo de nuevas vacunas
inferred← citeshttps://doi.org/10.1016/j.ejca.2020.10.014openalex-snapshot
Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2016.e00225openalex-snapshot
Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines
inferred← citeshttps://doi.org/10.1016/j.humimm.2024.111209openalex-snapshot
Combining anti-checkpoint immunotherapies and cancer vaccines as a novel strategy in oncological therapy: A review
inferred← citeshttps://doi.org/10.1016/j.humimm.2025.111557openalex-snapshot
An in-silico design of a multi-epitope vaccine candidate against human metapneumovirus (HMPV) through prediction of B- and T-cell epitopes and molecular dynamics simlation
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2021.04.005openalex-snapshot
Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2025.141152openalex-snapshot
A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture
inferred← citeshttps://doi.org/10.1016/j.ijpara.2014.07.010openalex-snapshot
Genome-based vaccine design: the promise for malaria and other infectious diseases
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2018.10.054openalex-snapshot
Encapsulation of Poly I:C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2021.121348openalex-snapshot
Lentinan PLGA-stabilized pickering emulsion for the enhanced vaccination
inferred← citeshttps://doi.org/10.1016/j.isci.2020.102021openalex-snapshot
A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
inferred← citeshttps://doi.org/10.1016/j.isci.2022.105324openalex-snapshot
Efficient antigen delivery by dendritic cell-targeting peptide via nucleolin confers superior vaccine effects in mice
inferred← citeshttps://doi.org/10.1016/j.isci.2026.117427openalex-snapshot
Proteomic analyses of seasonal human respiratory viruses unravel changes related to antiviral, inflammatory, and cell death pathways
inferred← citeshttps://doi.org/10.1016/j.jbc.2026.111423openalex-snapshot
Molecular mechanisms of immune evasion by host protein glycosylation of a bacterial immunogen used in nucleic acid vaccines
inferred← citeshttps://doi.org/10.1016/j.jconrel.2015.05.004openalex-snapshot
Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach
inferred← citeshttps://doi.org/10.1016/j.jconrel.2016.01.050openalex-snapshot
Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.12.022openalex-snapshot
Protein-based nanocages for vaccine development
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.02.027openalex-snapshot
In situ bio-mineralized Mn nanoadjuvant enhances anti-influenza immunity of recombinant virus-like particle vaccines
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.113629openalex-snapshot
Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant development
inferred← citeshttps://doi.org/10.1016/j.jim.2021.113055openalex-snapshot
Protective efficacy of Hla-MntC-SACOL0723 fusion protein adjuvanted in alum and MPL against Staphylococcus aureus sepsis infection in mice
inferred← citeshttps://doi.org/10.1016/j.jinf.2016.04.031openalex-snapshot
Systems immunology: Beyond antibody titers
inferred← citeshttps://doi.org/10.1016/j.jobb.2022.04.001openalex-snapshot
Application of microneedle-based vaccines in biosecurity
inferred← citeshttps://doi.org/10.1016/j.jprot.2019.01.010openalex-snapshot
High-resolution quantitative proteomics applied to the study of the specific protein signature in the sputum and saliva of active tuberculosis patients and their infected and uninfected contacts
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.120660openalex-snapshot
Modern vaccine development via reverse vaccinology to combat antimicrobial resistance
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.121332openalex-snapshot
Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections
inferred← citeshttps://doi.org/10.1016/j.micpath.2024.107226openalex-snapshot
K. pneumoniae ghosts serve as a novel vaccine formulation to enhance immune responses of A. baumannii subunit vaccine in mice
inferred← citeshttps://doi.org/10.1016/j.nec.2021.01.003openalex-snapshot
Brain Tumor Vaccines
inferred← citeshttps://doi.org/10.1016/j.nwnano.2024.100058openalex-snapshot
Nanotechnology platforms for antigen and immunostimulant delivery in vaccine formulations
inferred← citeshttps://doi.org/10.1016/j.sbi.2022.102348openalex-snapshot
Glycosylation as a key parameter in the design of nucleic acid vaccines
inferred← citeshttps://doi.org/10.1016/j.smim.2017.09.007openalex-snapshot
Modulating the immune system through nanotechnology
inferred← citeshttps://doi.org/10.1016/j.smim.2020.101423openalex-snapshot
Vaccines for neglected, emerging and re-emerging diseases
inferred← citeshttps://doi.org/10.1016/j.smim.2020.101433openalex-snapshot
Outer membrane vesicle vaccines
inferred← citeshttps://doi.org/10.1016/j.synbio.2023.11.004openalex-snapshot
Designing a multi-epitope vaccine against Peptostreptococcus anaerobius based on an immunoinformatics approach
inferred← citeshttps://doi.org/10.1016/j.tmaid.2022.102278openalex-snapshot
Travel vaccines throughout history
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.02.045openalex-snapshot
Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.11.062openalex-snapshot
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.02.027openalex-snapshot
Conjugation of PEG-hexadecane markedly increases the immunogenicity of pneumococcal polysaccharide conjugate vaccine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.11.069openalex-snapshot
Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.02.040openalex-snapshot
Killed but metabolically active Pseudomonas aeruginosa -based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections
inferred← citeshttps://doi.org/10.1016/j.vaccine.2019.10.087openalex-snapshot
Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.05.040openalex-snapshot
Experimental and molecular dynamics simulation studies on the physical properties of three HBc-VLP derivatives as nanoparticle protein vaccine candidates
inferred← citeshttps://doi.org/10.1016/j.vaccine.2025.127882openalex-snapshot
Recombinant truncated gD glycoprotein from E.coli as a thermostable and protective subunit vaccine candidate against ILTV in chickens
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128543openalex-snapshot
Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccination
inferred← citeshttps://doi.org/10.1016/j.virusres.2021.198454openalex-snapshot
The COVID-19 vaccine development: A pandemic paradigm
inferred← citeshttps://doi.org/10.1016/j.xcrp.2023.101249openalex-snapshot
Functional nucleic acids as potent therapeutics against SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/s2221-1691(15)30366-xopenalex-snapshot
The past, current and future trends in DNA vaccine immunisations
inferred← citeshttps://doi.org/10.1016/s2352-4642(20)30135-8openalex-snapshot
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
inferred← citeshttps://doi.org/10.1021/acs.accounts.7b00129openalex-snapshot
Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines
inferred← citeshttps://doi.org/10.1021/acs.analchem.1c00696openalex-snapshot
Epitope Mapping of Polyclonal Antibodies by Hydrogen–Deuterium Exchange Mass Spectrometry (HDX-MS)
inferred← citeshttps://doi.org/10.1021/acs.jcim.6c00679openalex-snapshot
SARS-CoV-2 Spike Protein’s Structural Dynamics Affect the Activity of the Bebtelovimab Antibody
inferred← citeshttps://doi.org/10.1021/acs.jctc.5c01810openalex-snapshot
Cracking the Capsid Code: A Computationally Feasible Approach for Investigating Virus–Excipient Interactions in Biologics Design
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01998openalex-snapshot
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c02215openalex-snapshot
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies
inferred← citeshttps://doi.org/10.1021/acs.langmuir.6b01720openalex-snapshot
Conserved Molecular Superlattices in a Series of Homologous Synthetic Mycobacterial Cell-Wall Lipids Forming Interdigitated Bilayers
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.0c00010openalex-snapshot
Conjugation of β-Glucan with the Hydrazone and Disulfide Linkers Markedly Improves the Immunogenicity of Zika Virus E Protein
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.6b00368openalex-snapshot
Nano-Self-Assemblies Based on Synthetic Analogues of Mycobacterial Monomycoloyl Glycerol and DDA: Supramolecular Structure and Adjuvant Efficacy
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.9b00908openalex-snapshot
Design of Gadoteridol-Loaded Cationic Liposomal Adjuvant CAF01 for MRI of Lung Deposition of Intrapulmonary Administered Particles
inferred← citeshttps://doi.org/10.1021/acsami.6b01135openalex-snapshot
Hyaluronic Acid-Modified Cationic Lipid–PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.6b00412openalex-snapshot
Biomaterials-Based Vaccination Strategies for the Induction of CD8+T Cell Responses
inferred← citeshttps://doi.org/10.1021/acschembio.5b00768openalex-snapshot
Deciphering Antigenic Determinants of Streptococcus pneumoniae Serotype 4 Capsular Polysaccharide using Synthetic Oligosaccharides
inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00005openalex-snapshot
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67
inferred← citeshttps://doi.org/10.1021/acsnano.0c02240openalex-snapshot
Suppressing Subcapsular Sinus Macrophages Enhances Transport of Nanovaccines to Lymph Node Follicles for Robust Humoral Immunity
inferred← citeshttps://doi.org/10.1021/jacs.2c13104openalex-snapshot
Glycan Stability and Flexibility: Thermodynamic and Kinetic Characterization of Nonconventional Hydrogen Bonding in Lewis Antigens
inferred← citeshttps://doi.org/10.1021/jacsau.6c00008openalex-snapshot
Chemical Strategy and AI-Enabled Peptide Vaccine Development
inferred← citeshttps://doi.org/10.1021/mp5006454openalex-snapshot
Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine
inferred← citeshttps://doi.org/10.1038/nsmb.3048openalex-snapshot
The Anopheles-midgut APN1 structure reveals a new malaria transmission–blocking vaccine epitope
inferred← citeshttps://doi.org/10.1038/s41390-020-01112-yopenalex-snapshot
The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems
inferred← citeshttps://doi.org/10.1038/s41392-021-00566-8openalex-snapshot
Application of 3D bioprinting in the prevention and the therapy for human diseases
inferred← citeshttps://doi.org/10.1038/s41392-021-00752-8openalex-snapshot
A novel inactivated whole-cell Pseudomonas aeruginosa vaccine that acts through the cGAS-STING pathway
inferred← citeshttps://doi.org/10.1038/s41467-018-02827-7openalex-snapshot
Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp
inferred← citeshttps://doi.org/10.1038/s41541-023-00781-0openalex-snapshot
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells
inferred← citeshttps://doi.org/10.1038/s41578-021-00399-5openalex-snapshot
Integrating plant molecular farming and materials research for next-generation vaccines
inferred← citeshttps://doi.org/10.1038/s41579-020-00506-3openalex-snapshot
The role of vaccines in combatting antimicrobial resistance
inferred← citeshttps://doi.org/10.1038/s41597-026-07298-wopenalex-snapshot
VO: The Vaccine Ontology
inferred← citeshttps://doi.org/10.1038/s41598-017-12996-yopenalex-snapshot
Immune Response of A Novel ATR-AP205-001 Conjugate Anti-hypertensive Vaccine
inferred← citeshttps://doi.org/10.1038/s41598-018-19874-1openalex-snapshot
Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo
inferred← citeshttps://doi.org/10.1038/s41598-018-22044-yopenalex-snapshot
Protective humoral and CD4+ T cellular immune responses of Staphylococcus aureus vaccine MntC in a murine peritonitis model
inferred← citeshttps://doi.org/10.1038/s41598-018-31995-1openalex-snapshot
Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses
inferred← citeshttps://doi.org/10.1038/s41598-020-60753-5openalex-snapshot
Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection
inferred← citeshttps://doi.org/10.1038/s41598-022-13790-1openalex-snapshot
Compilation of parasitic immunogenic proteins from 30 years of published research using machine learning and natural language processing
inferred← citeshttps://doi.org/10.1038/s41598-022-20346-wopenalex-snapshot
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
inferred← citeshttps://doi.org/10.1038/srep18099openalex-snapshot
Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination
inferred← citeshttps://doi.org/10.1039/9781837070206-00682openalex-snapshot
Machine Learning Applications in Vaccine Design
inferred← citeshttps://doi.org/10.1039/c6mb00268dopenalex-snapshot
New approaches and omics tools for mining of vaccine candidates against vector-borne diseases
inferred← citeshttps://doi.org/10.1039/c7bm01082fopenalex-snapshot
Photosensitizer-induced self-assembly of antigens as nanovaccines for cancer immunotherapy
inferred← citeshttps://doi.org/10.1039/c8bm01197dopenalex-snapshot
Up-to-date vaccine delivery systems: robust immunity elicited by multifarious nanomaterials upon administration through diverse routes
inferred← citeshttps://doi.org/10.1039/c9bm01183hopenalex-snapshot
A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response
inferred← citeshttps://doi.org/10.1039/d3nh00269aopenalex-snapshot
A catch-and-release nano-based gene delivery system
inferred← citeshttps://doi.org/10.1039/d5pm00017copenalex-snapshot
Vaccine formulation design: challenges and opportunities
inferred← citeshttps://doi.org/10.1042/ebc20200105openalex-snapshot
3D printing technologies forin vitrovaccine testing platforms and vaccine delivery systems against infectious diseases
inferred← citeshttps://doi.org/10.1073/pnas.1717160115openalex-snapshot
Technologies to address antimicrobial resistance
inferred← citeshttps://doi.org/10.1080/00207543.2024.2329317openalex-snapshot
Towards vaccine lifecycle management (VLM): A systematic literature review of the issues and challenges
showing the first 200 of 419 · page through all 419
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.